Journal article
Treatment Response With VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor, in Thyroid Eye Disease (TED): Phase 1/2 Clinical Study
Authors
Katz B; Turbin R; Cockerham K; Tang R; Nijhawan N; Ugradar S; O'Shaughnessy DJ; Summerfelt RM; She A; Douglas R
Journal
Endocrine Abstracts, , ,
Publisher
Bioscientifica
Publication Date
May 2, 2023
DOI
10.1530/endoabs.90.p750
ISSN
1470-3947